top of page
Delaney AIDS Research Enterprise (DARE)
Community Advisory Board
Lynda Dee is delighted to be working with the DARE research team who are genuinely community friendly, valuing and respecting community participation and input. She is extremely excited by their cutting edge scientific agenda which emphasizes the role of the immune system in HIV cure research.
Lynda is delighted to be leading DARE's community engagement efforts, and has very innovative plans for new DARE community outreach activities.
Michael is proud to serve as a co-chair for the DARE CAB. He has worked in HIV treatment research for 20+ years, engaging communities affected by HIV in Seattle and across the U.S. in clinical trials towards the treatment and potential elimination of HIV. He joined the defeatHIV Martin Delaney Collaboratory as their Community Engagement Project Manager in 2013, focusing his efforts around cell and gene therapies for HIV cure.
Nelson Vergel is a 36-year HIV survivor, health author, speaker and leading advocate for improved access to life-saving options for HIV+ people with limited treatment options and those with metabolic disorders. He holds a chemical engineering degree from McGill University and an MBA from the University of Houston.
Moisés Agosto-Rosario is a longtime treatment advocate and educator for people living with HIV and AIDS. A frequent public speaker and writer in both English and Spanish, Mr. Agosto-Rosario has played a crucial role in ensuring that communities of color have equal access to care, treatment, and lifesaving information and has won numerous awards for his work with the HIV community.
Danielle M. Campbell, MPH received a BS in Public Health from the University of California, Irvine and an MPH from Charles R. Drew University of Medicine and Science. Danielle is a Commissioner to the Los Angeles County Commission on HIV. She also serves as Governing Councilor to the HIV/ AIDS Section and Science Board of the American Public Health Association.
Matthew Chappell is a Licensed Clinical Social Worker in San Francisco, CA. Matt is a former member of ACT UP Golden Gate Treatment Issues Committee, former ACTG Community Advisory Board Member and Project Inform Volunteer. Matt has also participated Cure Research studies and is passionate about Cure Research.
Karine Dubé is honored to be affiliated with the Delaney AIDS Research Enterprise (DARE) Collaboratory as a member of the community. Her work bridges biomedical research, socio-behavioral sciences, empirical ethics and patient/community/stakeholder engagement in HIV cure-related research in the United States and South Africa. Karine is passionate about centering the voice of the patient in HIV cure-related research across the lifespan.
In his current role as TAG’s Basic Science, Vaccines and Cure Project Director, Richard Jefferys is particularly focused on HIV cure research education and advocacy. Among the project’s most widely used and cited resources is the regularly updated listing of HIV cure-related clinical trials and studies on the TAG website, which Richard created in 2014 as a spin-off from our annual Pipeline Reports.
Siegfried Schwarze is a trained microbiologist. After having worked in the pharmaceutical industry for some years he had to retire in 2000.
bottom of page